NCT00548080View on ClinicalTrials.gov

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Fungal Infection
Interventions
DRUG

MK0991, caspofungin acetate / Duration of Treatment:

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00548080 - Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) | Biotech Hunter | Biotech Hunter